Anti-PD-1 therapy combined with chemotherapy or target therapy in patients with advanced biliary tract cancer in real-world clinical setting

被引：0
|
作者：
Sun, D. [1 ]
Ma, J. [1 ]
Han, C. [1 ]
Wang, J. [1 ]
Qian, Y. [1 ]
Chen, G. [1 ]
Li, X. [1 ]
Zhang, J. [1 ]
Song, J. [2 ]
Zhao, X. [2 ]
Cai, S. [2 ]
Hu, Y. [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1230P
引用
收藏
页码：437 / 437
页数：1
相关论文
共 50 条
  • [1] Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting.
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Cai, Shangli
    Hu, Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
    Danyang Sun
    Junxun Ma
    Jinliang Wang
    Chun Han
    Yuanyu Qian
    Guangying Chen
    Xiaoyan Li
    Juan Zhang
    Pengfei Cui
    Wushuang Du
    Zhaozhen Wu
    Shixue Chen
    Xuan Zheng
    Zhichao Yue
    Jia Song
    Chan Gao
    Xiaochen Zhao
    Shangli Cai
    Yi Hu
    [J]. Cancer Immunology, Immunotherapy, 2019, 68 : 1527 - 1535
  • [3] Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Gao, Chan
    Zhao, Xiaochen
    Cai, Shangli
    Hu, Yi
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (09) : 1527 - 1535
  • [4] A retrospective cohort study of anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Han, Chun
    Qian, Yuanyu
    Chen, Guangying
    Li, Xiaoyan
    Zhang, Juan
    Cui, Pengfei
    Du, Wushuang
    Wu, Zhaozhen
    Chen, Shixue
    Zheng, Xuan
    Yue, Zhichao
    Song, Jia
    Zhao, Xiaochen
    Cai, Shangli
    Hu, Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Wang, Lijie
    Zhang, Sujie
    Chen, Guangying
    Li, Xiaoyan
    Cui, Pengfei
    Zheng, Xuan
    Hu, Yi
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1421 - +
  • [6] Effectiveness and safety of anti-PD-1 monotherapy or combination therapy in Chinese advanced gastric cancer: A real-world study
    Li, Tao
    Liu, Tingting
    Zhao, Lei
    Liu, Lu
    Zheng, Xuan
    Wang, Jinliang
    Zhang, Fan
    Hu, Yi
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [7] Combination therapy with lenvatinib and anti-PD-1 antibodies for unresectable or advanced hepatocellular carcinoma: A real-world study.
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    Huang, Cheng
    Shen, Ying-Hao
    Ge, Ning-Ling
    Chen, Yi
    Tan, Chang-Jun
    Zhou, Jian
    Fan, Jia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer
    Ge, Penglei
    Wu, Yang
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [9] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Bangyou Zuo
    Xiaobo Yang
    Xu Yang
    Jin Bian
    Junyu Long
    Dongxu Wang
    Cong Ning
    Yanyu Wang
    Ziyu Xun
    Yunchao Wang
    Xin Lu
    Yilei Mao
    Xinting Sang
    Haitao Zhao
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 1889 - 1896
  • [10] A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer
    Zuo, Bangyou
    Yang, Xiaobo
    Yang, Xu
    Bian, Jin
    Long, Junyu
    Wang, Dongxu
    Ning, Cong
    Wang, Yanyu
    Xun, Ziyu
    Wang, Yunchao
    Lu, Xin
    Mao, Yilei
    Sang, Xinting
    Zhao, Haitao
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (08) : 1889 - 1896
12345